Objective: The aim of this study was to examine the associations of demographic characteristics, health behaviors, and hormone concentrations with the experience of any, current, more severe, and more frequent midlife hot flashes.
H ot flashes are the most prevalent and most bothersome symptom reported by women during the menopausal transition. Recent estimates suggested that up to 80% of women experience hot flashes during midlife 1 and that, on average, symptoms last for approximately 10 years from symptom onset through the menopausal transition. 2 Hot flashes have been consistently shown to be associated with discomfort, sleep disturbances, fatigue, and decreased quality of life. 3 In addition, a recent study showed that, because of the negative effects of hot flashes on women's lives, women with hot flashes have lower work productivity and greater healthcare resource use than women without hot flashes. 4 There is also some indication that hot flashes are associated with an increased risk of more serious adverse health outcomes, including cardiovascular disease 5 and depression. 6 Despite the impact that hot flashes can have on a woman's life, little remains known, to date, about risk factors for hot flashes or the events that precipitate them. Several characteristics and health behaviors have more often than not been reported to be significantly associated with an increased risk of hot flashes during midlife, including cigarette smoking, [7] [8] [9] obesity, 7,10-12 and lower levels of education 9, [12] [13] [14] ; however, these associations have not been observed in all studies examining these relationships. 15 Other factors such as physical activity, alcohol intake, and reproductive history have also been examined in association with hot flashes; however, results pertaining to these risk factors have been less consistent than those reported for smoking, body mass index (BMI), and education. 16 A number of possible reasons may explain why the results of studies examining associations between risk factors and hot flashes have been inconsistent, such as (1) the populations undergoing study were composed of women of different race and ethnic backgrounds and (2) the measurement of hot flashes varied from a single question to a more detailed hot flash history.
Since 2006, the longitudinal Midlife Women's Health Study has been conducted to examine risk factors for hot flashes in a large population-based cohort study of women undergoing the midlife transition. In the Midlife Women's Health Study, detailed information on the experience of hot flashes is collected annually by self-report, and clinic visits are conducted to measure height and weight, to collect blood samples for hormone measurements, and to obtain ovarian volume measurement using transvaginal ultrasound. The objective of this analysis was to describe the baseline characteristics of the cohort and to report (using the data collected at baseline) the associations of demographic characteristics, health behaviors, and hormone concentrations with the experience of any, more severe, and more frequent hot flashes.
METHODS

Study participants
The Midlife Women's Health Study is a cohort study of hot flashes among midlife women (aged 45-54 y) that began in 2006, enrolling residents of the Baltimore metropolitan region, which includes Baltimore city and its surrounding counties. Detailed methods of this study are described in Gallicchio et al. 15 All participants gave written informed consent in accordance with the procedures approved by the University of Illinois and Johns Hopkins University Institutional Review Boards.
Briefly, women in the selected age range were recruited through mass mailings in the targeted region. Women who were interested in participating in this study, which was presented as a general ''midlife health study'' to avoid reporting bias, were invited to call the clinic to obtain more information. During this call, the clinic staff determined whether the woman met the eligibility criteria. Women were eligible if they were aged between 45 and 54 years, had intact ovaries and uterus, and were either premenopausal or perimenopausal. Women were excluded if they were pregnant, had a history of cancer, or were postmenopausal. Women who were taking exogenous female hormones or herbal/plant substances were also excluded so that risk factors for hot flashes could be studied without the confounding effects of known treatments for hot flashes. Menopause status was defined as follows: premenopausal women were those who experienced their last menstrual period within the past 3 months and reported 11 or more periods within the past year; perimenopausal women were those who experienced (1) their last menstrual period within the past year, but not within the past 3 months or (2) their last menstrual period within the past 3 months and experienced 10 or fewer periods within the past year; and postmenopausal women were those who had not experienced a menstrual period within the past year.
If women were eligible and interested in participating in the study, she was asked to make a clinic visit (baseline visit) to a Johns Hopkins clinical site. During this baseline clinic visit, the participant completed the detailed 26-page baseline study survey, donated blood and urine samples, was weighed and measured (height), had her blood pressure measured, and underwent transvaginal ultrasound to measure ovarian volume. Each participant was asked to visit the clinic once per week for the 3 weeks following the baseline visit so that the study staff could obtain additional blood and urine samples. Women also completed a brief questionnaire at the last of the three weekly visits after the baseline visit. These four consecutive weekly clinic visits were repeated on a yearly basis throughout the woman's participation in the study. Only data from the baseline clinic visit were analyzed in this study.
Through April 2014, 736 women were enrolled in the study, of which 734 completed the baseline clinic visit and questionnaire. After enrolling into the study and completing the clinic visit, two women were determined to be postmenopausal and thus ineligible at baseline. Therefore, the final analytic data set was composed of 732 premenopausal and perimenopausal women.
Study variables
On the study questionnaires, hot flashes were defined as ''a sudden feeling of heat in the face, neck, or upper part of the chest. Hot flashes are often accompanied by reddening or flushing of the skin followed by sweating and chills.'' At baseline, a detailed hot flash history was obtained through a series of questions on the survey that asked for information on the following: whether the woman had ever experienced hot flashes, whether she had a hot flash in the past 30 days, the usual severity of hot flashes, the frequency of hot flashes, and the length of time that the woman experienced hot flashes. Women who responded ''no'' to ''Ever experienced hot flashes?'' were prompted to skip the more detailed hot flash questions. The hot flash questions chosen for inclusion in the questionnaires have been used to collect data on hot flashes in midlife health studies for more than 10 years.
For severity, each woman was asked to describe her hot flashes as mild (sensation of heat without sweating), moderate (sensation of heat with sweating), or severe (sensation of heat with sweating that disrupts usual activity). For frequency of hot flashes, each woman was asked to describe her hot flashes as occurring every hour, every 2 to 5 hours, every 6 to 11 hours, every 12 to 23 hours, 1 to 2 days per week, 5 to 6 days per week, 2 to 3 days per month, 1 day per month, less than 1 day per month, or never. For analysis of the data, the following hot flash variables were examined as dependent variables (outcomes): ever experienced hot flashes (yes vs no); experienced any hot flashes in the past 30 days (yes vs no); moderate or severe hot flashes (yes vs no); and weekly or daily hot flashes (yes vs no).
Height and weight measured at the clinic visit were used to calculate BMI (categorized as <25, 25-29.9, or !30 kg/m 2 ).
Smoking was categorized as current, former, or never using the questions, ''Have you ever smoked cigarettes?'' and ''Do you still smoke cigarettes?'' Similarly, alcohol intake data were collected using the following questions: ''During your entire life, have you had at least 12 drinks of any kind of alcoholic beverage?'' and ''In the last 12 months, have you had at least 12 drinks of any kind of alcoholic beverage?'' For those responding that they had had at least 12 drinks in the last 12 months, further queries were made regarding the number of RISK FACTORS FOR MIDLIFE HOT FLASHES days per month (on average) that the woman drank and the number of drinks that the woman drank on those days. Physical activity was assessed by the participant's response to the question, ''In comparison with others my own age, I think my physical activity during leisure time is [choices: much more, more, as much, less, and much less].'' Employment status was categorized as employed (either full time or part time) or not employed. Medication use information was provided by the participant. The presence of depressive symptoms was assessed using the Centers for Epidemiologic Studies-Depression Scale. 17 Individuals with a score of 16 or higher were identified as having depressive symptoms. Data on race, education, and reproductive history were also collected on the questionnaire.
Ovarian volume
Transvaginal ultrasound was performed, using the 7.5-MHz transvaginal probe on a GE transvaginal ultrasound machine, to collect data on ovarian volume. Examination of the ovary was established by scanning from the outer margin to the inner margin. All transvaginal ultrasound measurements were conducted by highly trained physicians in the Department of Gynecology and Obstetrics at Johns Hopkins University. The physicians used a highly standardized protocol for measurements on calibrated equipment. In pilot studies, ultrasound measurements were determined to be highly repeatable. For example, when two different physicians performed ovarian size measurements on the same participant, the values were very close to each other (eg, physician 1: right ovary, 2.98 cm Â 2.05 cm Â 2.04 cm; physician 2: right ovary, 2.75 cm Â 1.95 cm Â 1.71 cm). Given the extensive training and experience of the physicians performing the transvaginal ultrasound, the use of calibrated equipment, and the repeatability of results, solid quality control for transvaginal ultrasound was in place for this study.
Hormone assays
Serum concentrations of estradiol, testosterone, and progesterone were measured in blood samples collected at each clinic visit. Women were asked to donate blood at four clinic visits across 4 weeks on year 1 (baseline) and in each subsequent year of participation in the study; however, not all women were able to attend all four clinic visits on year 1 or in follow-up years. In year 1, 82.0% of participants completed all four visits, 12.2% completed three visits, 2.3% completed two visits, and 3.5% completed only one visit. A single concentration value for year 1 and for each subsequent follow-up year was calculated using the average value of the hormone concentrations measured in each year.
Estradiol, testosterone, and progesterone concentrations were measured using enzyme-linked immunosorbent assays (ELISA kit; Diagnostic Systems Laboratories Inc, Webster, TX). Assays were run according to the manufacturer's instructions. 18 All assays were conducted in the same laboratory. All samples were run in duplicate, and the mean values for each participant were used in the analysis. Laboratory personnel were blinded to any information concerning study participants. For quality control purposes, samples from both women with hot flashes and women without hot flashes were run within the same laboratory batches. In addition, positive controls containing known amounts of estradiol, testosterone, and progesterone were included in each batch. Furthermore, some samples were run in multiple assays to ensure that assay values did not dramatically shift across time.
The minimal detection limits and intra-assay coefficients of variation were as follows: estradiol 7 pg/mL, 3.3% (0.17%); testosterone 0.04 ng/mL, 2.2% (0.56%); and progesterone 0.1 ng/mL, 2.1% (0.65%). The average interassay coefficient of variation for all assays was less than 5%.
Statistical analysis
Hormone concentration data were log-transformed because the values were not normally distributed. Normality was assessed by examining the distribution of hormone concentrations among women with hot flashes and women without hot flashes. Univariate analyses were performed by calculating frequencies for categorical variables and geometric means for continuous log-transformed hormone variables. Differences in demographic, reproductive, and health habit characteristics by hot flash status (ever vs never) were examined using x 2 test for categorical variables; differences in hormone concentrations by hot flash status were examined using generalized linear models.
To examine age-and covariate-adjusted associations between participant characteristics, hormone concentrations, and each hot flash outcome, odds ratios (ORs) and 95% CIs were estimated using logistic regression models. Variables that have been consistently reported in the published literature to be associated with hot flashes, as well as those shown in bivariate analyses to be significantly associated with a history of hot flashes at P < 0.05, were included in all covariateadjusted models. Hormone concentrations were not included as covariates in covariate-adjusted models as they may represent the mechanism by which certain risk factors are associated with hot flashes. Furthermore, models examining the association between a hormone and a hot flash outcome were not adjusted for other hormone concentrations.
All analyses were conducted among the total sample and by race (white and black). However, race was not determined to be an effect modifier of associations; thus, race-stratified results are not presented. Analyses were performed using SAS version 9.2 (SAS Institute Inc, Cary, NC). Two-sided P < 0.05 was considered statistically significant.
RESULTS
At baseline, 45.4% of study participants reported experiencing midlife hot flashes. Characteristics of women with a history of hot flashes and women without a history of hot flashes are presented in Table 1 . Women with a history of hot flashes were more likely to be older, to have graduated from college, to be current or former smokers, to be perimenopausal, to have depressive symptoms, and to be taking antihypertensive medications than women without hot flashes. Mean estradiol and progesterone concentrations were significantly lower among women reporting hot flashes than among those not reporting hot flashes. Similarly, mean ovarian volume was lower among women with hot flashes than among women without hot flashes.
Among women who had a history of midlife hot flashes, most reported experiencing hot flashes in the previous 30 days (72.3%; Table 2 ). Approximately 9% of these women reported their hot flashes as usually being severe, with 55.7% reporting their hot flashes as being moderate. About a quarter of those with hot flashes reported experiencing them daily, and 26.2% reported experiencing hot flashes weekly. Most women with hot flashes had experienced them for 1 to 4 years (44.9%).
Age-and covariate-adjusted associations of participant characteristics and hormone concentrations with hot flash outcomes (history of hot flashes, current hot flashes, moderate to severe hot flashes, and weekly or daily hot flashes) are shown in Tables 3 and 4 . In covariate-adjusted models, older age, perimenopause status, current and past cigarette smoking, and depressive symptoms were significantly associated with increased odds of all of the hot flash outcomes. Perimenopause status was the factor most strongly related to hot flash outcomes, with ORs ranging from 5.34 (history of hot flashes) to 12.42 (weekly or daily hot flashes) for perimenopausal versus premenopausal women. In addition, after adjustment for covariates, history of oral contraceptive use was associated with increased odds of ever experiencing hot flashes (OR, 1.89; 95% CI, 1.16-3.08). In contrast, higher current alcohol intake (more than one drink per day) was significantly associated with decreased odds of ever experiencing hot flashes, currently experiencing hot flashes, and moderate to severe hot flashes.
Higher estradiol and progesterone concentrations were significantly associated with decreased odds of all of the hot flash outcomes after adjustment for age, race, education, BMI, smoking, alcohol intake, and menopause status. Testosterone concentration was not significantly associated with any of the hot flash outcomes. Ovarian volume was 
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significantly associated with all outcomes in age-adjusted, but not covariate-adjusted, analyses.
DISCUSSION
This study examined risk factors for experiencing any, current, more severe, and more frequent hot flashes among women aged 45 to 54 years who were participating in the Midlife Women's Health Study. Results of this study showed that older age, perimenopause status, cigarette smoking, and depressive symptoms were associated with a statistically significantly increased risk of all of the hot flash outcomes. Conversely, greater alcohol intake and higher estradiol and progesterone concentrations were associated with a decreased risk of hot flashes. In general, the strength of the association with each risk factor was similar across all outcomes, except for menopause status, where the OR for more frequent hot flashes was twice that for other hot flash outcomes. The consistency of the ORs suggests that the hot flashes associated with certain risk factors are likely to be consistent in nature themselves-primarily moderate to severe in nature and experienced on a weekly or daily basis. Furthermore, the stronger association between menopause status and frequency of hot flashes confirms clinical and research findings that the frequency of hot flashes increases during perimenopause. In total, the results of this study add to previously published findings in that more detailed data on hot flashes were collected than in previous studies, allowing for a more thorough understanding of the role of certain factors in the development of midlife hot flashes.
Cigarette smoking is the factor that has been most consistently reported in previously published studies to be associated with midlife hot flashes. [7] [8] [9] 13, 19 Results from the present study confirm these previous findings. Specifically, current smoking was associated with a 2.6-fold increased odds of ever experiencing hot flashes and, further, a 3.4-to 3.8-fold increased odds of experiencing current, more severe, and more frequent hot flashes. Former smokers were also at significantly increased risk for all hot flash outcomes, although the increase in odds was not as great as in current smokers compared with those who never smoked. A number of mechanisms for the increased risk of hot flashes associated with cigarette smoking have been postulated, including the antiestrogenic effects of smoking. 20 However, in this study, consistent with what has been reported in several other previously published studies, 8, 21 addition of estradiol in multivariable-adjusted models as a covariate for cigarette smoking did not attenuate OR estimates (data not shown), indicating that other mechanisms may be involved. Such mechanisms could include alterations in neurotransmitter metabolism within the dopaminergic system, as hypothesized by Butts et al. 22 In the present study, alcohol intake was significantly associated with decreased odds of experiencing any, current, and more severe hot flashes after adjustment for other risk factors and covariates, although there was little evidence of a dose-response relationship observed for drinks per day in the analyses. Alcohol intake is a factor that has been shown in published studies to be associated with both increased 19, 23, 24 and decreased 25, 26 risk of midlife hot flashes. Some evidence indicates that alcohol intake increases estrogen concentrations, 27, 28 supporting our finding of a decreased risk of hot flashes with more alcohol intake, as hot flashes are thought to be associated with low estradiol levels. However, similar to cigarette smoking, OR estimates for hot flash outcomes associated with alcohol intake did not change after the addition of estradiol, or progesterone, to the multivariable model (data not shown). An alternative mechanism is that perhaps much of the alcohol consumed by participants in this study was in the form of wine, and that a major component of wine-resveratrol-exerts health benefits such as lowered oxidative stress, 29 leading to a decreased risk of hot flashes. We did not collect data on type of alcohol consumed (eg, beer, wine, and spirits); thus, considering wine as the most common type of alcoholic beverage consumed is speculative based on the demographic characteristics of this study sample. Furthermore, whether there is a relationship between oxidative stress and hot flashes is unknown, although some data suggest such an association. 30 The relationship between alcohol intake and hot flashes could also be bidirectional, with women with hot flashes increasing the amount of alcohol consumed.
Depressive symptoms were also significantly associated with the occurrence of hot flashes in this study. As this analysis was cross-sectional in nature, the temporality of the association between depressive symptoms and hot flashes is not clear. A recently published systematic review by Worsley et al 31 on the association between vasomotor symptoms and depression during the menopausal transition concluded that there is a positive bidirectional association between vasomotor symptoms and depression during perimenopause, with women with depressive symptoms more likely to develop vasomotor symptoms and with women with vasomotor symptoms more likely to develop depressive symptoms. The systematic review was based on 17 crosssectional studies and 12 cohort studies, although three large 32, 33 Adjustment for hormone concentrations in covariate-adjusted models did not attenuate OR estimates between hot flashes and depressive symptoms (data not shown), suggesting that hormones do not mediate the association. BMI was not associated with any of the hot flash outcomes in this study. This finding, as well as a more in-depth discussion of BMI results, was reported in a previous publication from the same cohort. 15 In brief, why the findings of this study differ from those of similar studies is unclear. One possibility is that the perimenopausal women in our cohort study were in the later stage of perimenopause compared with women in other similar studies of midlife women. Data collected in the study allowed us to determine whether a woman was premenopausal, perimenopausal, or postmenopausal; however, it was not possible to know from our data how early the participants were in each stage and how this compares to different studies. Thus, we can only speculate that the reported differences in the association between BMI and hot flashes among studies are attributable to differences in where participants are in each stage of the menopausal transition.
Similarly, physical activity and reproductive factors (such as having ever been pregnant, number of pregnancies, age at menarche, and age at first birth) were also not significantly associated with midlife hot flashes in this study. In the published literature, findings on hot flashes, physical activity, and reproductive history have been inconsistent 13, 16, [34] [35] [36] [37] [38] [39] [40] [41] [42] and, therefore, have not contributed to the identification of risk factors that could help provide clues to the etiology of hot flashes or measures that could prevent the onset of hot flashes.
There has been much controversy about the etiology of midlife hot flashes. Numerous studies have examined the role of sex steroid hormones in hot flash etiology, with much of the focus being on estradiol. As shown in this study and in other longitudinal investigations, 9, 43, 44 the risk of hot flashes increases during the menopausal transition, a period when estradiol concentrations decline dramatically. The finding of a statistically significant increase in the odds of hot flashes associated with a decrease in estradiol concentration in this study is consistent with previous cross-sectional and longitudinal studies [45] [46] [47] [48] [49] ; estrogen is thought to be involved in thermoregulatory homeostasis in the hypothalamus. 50 In contrast to numerous studies reporting on estradiol and hot flashes, the association between lower progesterone concentrations and increased risk of hot flashes observed in the present study has only been reported in one previous study conducted by our research group, 47 although many studies have shown that progestin therapies are effective in reducing or preventing hot flashes in perimenopausal women (eg, Prior and Hitchcock, 51 Hitchcock and Prior, 52 and Ruiz and Daniels 53 ). Some evidence indicates that progestins, similar to estrogens, interact with several neurotransmitter pathways in the hypothalamus that are responsible for thermoregulation. 54 There is a paucity of information on progesterone and on the etiology of menopausal symptoms; thus, future work should focus on this area.
This study has several limitations that should be considered. First, this analysis was cross-sectional in nature; thus, we are unable to determine the temporality of the observed associations with hot flashes. Second, the study sample, although relatively large, was well-educated and included mostly black and white women. Therefore, there may be selection bias in this study, and the results may not be generalizable to all midlife women. Finally, most of the data collected in this study, including data on hot flashes, were based on self-report and not on objective measurements. We elected to use self-reported occurrence of hot flashes rather than a physiologic assessment of their occurrence primarily because physiologic measurement of hot flashes is technically difficult and has not been validated in large populations. Most population-based studies have used self-report as a valid measure of hot flashes, 2, 8 and the National Institutes of Health 55 accepts self-report as a valid indicator of hot flashes.
A major strength of this study was the collection of detailed data on hot flashes-present and past experience of any, more severe, and more frequent hot flashes. Few studies examining risk factors for hot flashes have collected such detailed data; most have relied on a single hot flash question or have focused on hot flash experience within a brief period (ie, the previous 4 wk). A second strength was the collection of multiple blood samples across a 4-week period for each participant. The CONCLUSIONS This study shows that older age, perimenopause status, cigarette smoking, and depressive symptoms are factors associated with a statistically significantly increased risk of the experience of any, current, more severe, and more frequent hot flashes among midlife women. Conversely, greater alcohol intake and higher estradiol and progesterone concentrations are associated with a decreased risk of hot flashes. Although the temporality of such associations is not known because of the cross-sectional nature of the data, these observed relationships can help to identify women at risk for menopausal hot flashes and can provide intervention strategies (eg, quitting cigarette smoking) to reduce risk. As the Midlife Women's Health Study cohort continues to be followed, future analyses will examine the factors investigated in this study (including hormone concentrations) and their relationship with hot flashes during the menopausal transition. OR, odds ratio. a Covariates included in all multivariable models: participant age, race, education, body mass index, smoking, alcohol intake, and menopause status.
